Peptide sciences tirzepatide targets both GIP and GLP-1 receptors, while peptide sciences semaglutide targets only GLP-1. Dual agonism may produce distinct metabolic research outcomes.
Peptide sciences tirzepatide targets both GIP and GLP-1 receptors, while peptide sciences semaglutide targets only GLP-1. Dual agonism may produce distinct metabolic research outcomes.
Leave A Comment